HomeAC6 • FRA
add
AlzeCure Pharma AB
Previous close
€0.15
Day range
€0.14 - €0.14
Year range
€0.12 - €0.44
Market cap
216.61M SEK
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.88M | 84.19% |
Net income | -17.74M | -90.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -17.58M | -82.04% |
Effective tax rate | 0.02% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.34M | 59.81% |
Total assets | 59.04M | 71.46% |
Total liabilities | 26.12M | 216.63% |
Total equity | 32.92M | — |
Shares outstanding | 114.91M | — |
Price to book | 0.51 | — |
Return on assets | -71.15% | — |
Return on capital | -100.46% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.74M | -90.16% |
Cash from operations | -8.58M | -13.40% |
Cash from investing | — | — |
Cash from financing | -275.00K | — |
Net change in cash | -8.85M | -15.15% |
Free cash flow | -2.05M | 53.70% |
About
Founded
2012
Website
Employees
11
